Charles River Laboratories (CRL) Stock Forecast & Price Target
Charles River Laboratories · NYSE
$234.79-5.64 (-2.35%)
15-min delayed · Jul 29, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 12 firms covering Charles River Laboratories, 8 rate it Buy or better, 4 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $160.00 to $265.00, a moderate spread. The average target of $216.18 sits 8% below the current $234.79. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $3.05 next quarter toward $12.33 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 ratings
Moderate Buy
Strong Buy00%
Buy867%
Hold433%
Sell00%
Strong Sell00%
Based on 12 analysts giving stock ratings to Charles River Laboratories.
As of Jul, 8 of 12 firms rate CRL a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CRL EPS & revenue forecast
EPS · NEXT QUARTER
$3.05
Range $2.89 – $3.12 · 13 analysts · +25% YoY
Next period, 13 analysts expect Charles River Laboratories to earn $3.05 a share (range $2.89 – $3.12), versus $2.43 a year earlier. Full-year consensus is $11.10, growing to $12.33 the year after.
REVENUE · NEXT QUARTER
$939.2M
Range $926.6M – $954.3M · 13 analysts · -7% YoY
Revenue is expected to reach $939.2M (range $926.6M – $954.3M), -6.5% year-over-year. Full-year consensus is $3.8B, rising to $3.9B next year.
Top analysts covering Charles River Laboratories
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CRL.
#1
Luke Sergott
Barclays · Rank #194
Buy
$220.00-6.3% to target
Overall win rate
41%
+ Follow
#2
Patrick Donnelly
Citigroup · Rank #260
Buy
$265.00+12.9% to target
Overall win rate
32%
+ Follow
#3
Ann Hynes
Mizuho
Hold
$230.00-2.0% to target
Coverage
—
+ Follow
#4
RM
Ross Muken
Evercore ISI Group
Buy
$220.00-6.3% to target
Coverage
—
+ Follow
#5
CW
Casey Woodring
JP Morgan
Hold
$160.00-31.9% to target
Coverage
—
+ Follow
CRL stock forecast FAQ
What is CRL's average 12-month price target?+
The 11 analysts with a live target average $216.18 for Charles River Laboratories over the next 12 months, ranging from a $265.00 high to a $160.00 low.
Is CRL stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 12 analyst ratings, 8 are Buy or Strong Buy, 4 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CRL?+
The Street-high target is $265.00 (Citigroup), and the Street-low is $160.00 (JP Morgan). The average of all 11 active targets is $216.18.
How many Wall Street analysts cover CRL?+
12 analysts have an active rating on Charles River Laboratories, and 11 firms carry a live 12-month price target.
Who is the most accurate analyst covering CRL?+
Among analysts who currently cover CRL, Luke Sergott of Barclays has the strongest overall Quantellect track record (Rank #194). Their current call is Buy with a $220.00 target.
What is Charles River Laboratories's projected EPS for next quarter?+
The consensus estimate is $3.05 per share (range $2.89 – $3.12) across 13 analysts. Full-year EPS is projected at $11.10, rising to $12.33 the following year.
How much revenue is Charles River Laboratories expected to report next quarter?+
Consensus revenue is $939.2M (range $926.6M – $954.3M). Full-year revenue is projected at $3.8B, growing to $3.9B next year.
Have analysts been upgrading or downgrading CRL lately?+
As of Jul, 8 of 12 firms rate CRL a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CRL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
